Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Enlivex Ltd. - SIC # 2830 -
Ticker
Exchange
SIC #
Website
Latest Ticker
ENLV
Nasdaq
2830
www.enlivex.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Enlivex Ltd.
Enlivex Ltd. (ENLV) Upgraded to Buy: Here's Why
- Jul 13th, 2026 10:00 am
Enlivex Ltd. (ENLV) Loses 31.7% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
- Jul 13th, 2026 7:35 am
Exclusive: FDA grants RMAT designation to Enlivex’s Allocetra for knee OA
- Jul 13th, 2026 5:30 am
Enlivex advances Allocetra while expanding into prediction markets
- May 11th, 2026 11:39 am
Enlivex to Present Phase IIa 3-month and 6-month Data of Allocetra at OARSI 2026 World Congress
- Apr 23rd, 2026 6:30 am
H.C. Wainwright Highlight Improved Balance Sheet Supporting Enlivex Ltd. (ENLV) Outlook
- Apr 20th, 2026 8:46 pm
Ondo Global Markets Tokenizes Enlivex’s Ordinary Shares
- Apr 8th, 2026 6:30 am
Enlivex Therapeutics Q4 Earnings Call Highlights
- Mar 25th, 2026 8:18 am
Off The Hook Yachts and Enlivex Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
- Mar 20th, 2026 7:00 am
Enlivex Therapeutics announces new listing of RAIN token on Kraken
- Feb 11th, 2026 6:11 am
RedChip Fintech & DATS Conference Replays Now Available Featuring Public Companies Shaping the Future of Digital Finance
- Feb 9th, 2026 12:30 pm
RedChip Spotlights the Future of Finance at Fintech & Digital Asset Treasury Strategy (DATS) Virtual Investor Conference on February 4
- Jan 27th, 2026 7:35 am
Enlivex Therapeutics Shares to Trade Exclusively on Nasdaq
- Jan 23rd, 2026 6:00 am
Nasdaq biotech firm bets $212m on new Arbitrum-based prediction market
- Nov 25th, 2025 10:14 am
Enlivex Unveils $212M Rain Token DAT Strategy as RAIN Surges Over 120%
- Nov 24th, 2025 2:51 pm
BC-Most Active Stocks
- Nov 24th, 2025 8:30 am
Microcap Biotech Firm Raises $212M for Prediction Market Token Treasury Strategy
- Nov 24th, 2025 6:00 am
EXCLUSIVE: Enlivex Raises Over $200 Million To Launch First Public Company Prediction Markets Play
- Nov 24th, 2025 5:46 am
Enlivex Announces Positive 6-Month Topline Data –Demonstrating Durable and Persistent Pain Reduction and Improved Function in Primary Age-Related Patients with Moderate to Severe Knee Osteoarthritis
- Nov 24th, 2025 4:40 am
Scroll